NCT06980116
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06980116
Title Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | ESP

Facility Status City State Zip Country Details
LLC ARENSIA Exploratory Medicine RECRUITING Tbilisi 119 Georgia Details
IMSP Institute of Oncology, ARENSIA Exploratory Medicine RECRUITING Chisinau MD-2025 Moldova Details
Hospital Beata Maria Ana RECRUITING Madrid 28007 Spain Details
Hospital Fundación Jiménez Diaz RECRUITING Madrid Spain Details
Hospital Universitario HM Sanchinarro RECRUITING Madrid Spain Details
Clinica Universidad de Navarra RECRUITING Pamplona 31008 Spain Details
Medical Center of LLC ARENSIA Exploratory Medicine RECRUITING Kyiv 01135 Ukraine Details
St James's University Hospital RECRUITING Leeds United Kingdom Details
University Hospitals Plymouth NHS Trust (Derriford Hospital) RECRUITING Plymouth United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field